Home
Aspira Pathlab & Diagnostics Ltd PE Ratio

Aspira Pathlab & Diagnostics Ltd
NSE: ASPIRAPATHLAB
PE
Key Highlights
- The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 98.7 as of 02 Apr 9.00 AM .
- The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 21.3 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
- The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 80.97 as of 01 Apr 15:30 .
- The PE Ratio of Healthcare Industry has changed from 35.5 to 62.3 in 5 years. This represents a CAGR of 11.91%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.3. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd
Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Ltd
NSE: ASPIRAPATHLAB
Share Price
Market Price of Aspira Pathlab & Diagnostics Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
01 Apr 2025 | 80.97 |
28 Mar 2025 | 85.23 |
27 Mar 2025 | 89.71 |
26 Mar 2025 | 94.43 |
25 Mar 2025 | 99.39 |
24 Mar 2025 | 101.7 |
21 Mar 2025 | 96.86 |
20 Mar 2025 | 92.25 |
19 Mar 2025 | 88 |
18 Mar 2025 | 88 |
SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd
BlinkX Score for Aspira Pathlab & Diagnostics Ltd
Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Aspira Pathlab & Diagnostics Ltd | 83.34 | 98.74 |
Max Healthcare Institute Ltd | 105332 | 99.3 |
Apollo Hospitals Enterprise Ltd | 95328 | 72.8 |
Fortis Healthcare Ltd | 51971 | 65.9 |
Narayana Hrudayalaya Ltd | 34261 | 43.7 |
Global Health Ltd | 33068 | 65.2 |
Company | |
---|---|
Aspira Pathlab & Diagnostics Ltd | 83.34 |
Max Healthcare Institute Ltd | 105332 |
Apollo Hospitals Enterprise Ltd | 95328 |
Fortis Healthcare Ltd | 51971 |
Narayana Hrudayalaya Ltd | 34261 |
Global Health Ltd | 33068 |
PE Ratio of Aspira Pathlab & Diagnostics Ltd Explained
₹83.34
Market cap
₹0
Earnings
98.7X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Healthcare Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Aspira Pathlab & Diagnostics Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Aspira Pathlab & Diagnostics Ltd
Historical Revenue, EBITDA and Net Profit of Aspira Pathlab & Diagnostics Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Aspira Pathlab & Diagnostics Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Aspira Pathlab & Diagnostics Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Aspira Pathlab & Diagnostics Ltd
About Aspira Pathlab & Diagnostics Ltd
- Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
- ASDL is a leading pathology specialist, with Pan-India presence.
- It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
- The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
- Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'.
Aspira Pathlab & Diagnostics Ltd News Hub
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter
Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as
Read more
14 Aug 24
Aspira Pathlab & Diagnostics to announce Quarterly Result
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 13 Augu
Read more
05 Aug 24
Aspira Pathlab & Diagnostics AGM scheduled
Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be
Read more
28 Aug 24
Aspira Pathlab & Diagnostics schedules board meeting
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 Nove
Read more
30 Oct 24